197
Views
1
CrossRef citations to date
0
Altmetric
Review

Incremental Hemodialysis: What We Know so Far

ORCID Icon, &
Pages 161-172 | Published online: 29 Apr 2022

References

  • Hemodialysis Adequacy Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S2–S90. doi:10.1053/j.ajkd.2006.03.051
  • Caria S, Cupisti A, Sau G, Bolasco P. The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol. 2014;15:172. doi:10.1186/1471-2369-15-172
  • Mendonca S, Bhardwaj S, Sreenivasan S, Gupta D. Is twice-weekly maintenance hemodialysis justified? Indian J Nephrol. 2021;31(1):27–32. doi:10.4103/ijn.IJN_338_19
  • Rhee CM, Unruh M, Chen J, Kovesdy CP, Zager P, Kalantar-Zadeh K. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial. 2013;26(6):720–727. doi:10.1111/sdi.12133
  • Yan Y, Wang M, Zee J, et al. Twice-weekly hemodialysis and clinical outcomes in the China dialysis outcomes and practice patterns study. Kidney Int Rep. 2018;3(4):889–896. doi:10.1016/j.ekir.2018.03.008
  • Blagg CR. The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am J Kidney Dis. 2007;49(3):482–496. doi:10.1053/j.ajkd.2007.01.017
  • Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–2019. doi:10.1056/NEJMoa021583
  • Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985;28(3):526–534. doi:10.1038/ki.1985.160
  • Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287–2300.
  • DOPPS practice monitor - hemodialysis; 2021. Available from: https://www.dopps.org/DPM-HD/DPMSlideBrowser.aspx?type=ComGrp&id=18. Accessed October 11, 2021.
  • Trish E, Fiedler M, Ning N, Gascue L, Adler L, Lin E. Payment for dialysis services in the individual market. JAMA Intern Med. 2021;181(5):698–699. doi:10.1001/jamainternmed.2020.7372
  • Murea M, Moossavi S, Fletcher AJ, et al. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial. BMJ Open. 2021;11(5):e047596. doi:10.1136/bmjopen-2020-047596
  • Golper TA, Mehrotra R. The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant. 2015;30(10):1602–1604. doi:10.1093/ndt/gfv271
  • Vilar E, Farrington K. Emerging importance of residual renal function in end-stage renal failure. Semin Dial. 2011;24(5):487–494. doi:10.1111/j.1525-139X.2011.00968.x
  • Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7(2):198–207. doi:10.1681/ASN.V72198
  • Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–2162. doi:10.1681/ASN.V12102158
  • Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–1320. doi:10.1681/ASN.V1351307
  • Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant. 1998;13(Suppl 6):10–14. doi:10.1093/ndt/13.suppl_6.10
  • Churchill BM, Patri P. The nitty-gritties of Kt/V (urea) calculations in hemodialysis and peritoneal dialysis. Indian J Nephrol. 2021;31(2):97–110. doi:10.4103/ijn.IJN_245_19
  • Meyer TW, Blanco IJ, Grimm JC, Leypoldt JK, Sirich TL. Barriers to reducing hemodialysis time and frequency in patients with residual kidney function. J Am Soc Nephrol. 2021;32(9):2112–2116. doi:10.1681/ASN.2021030361
  • Daugirdas JT, Depner TA, Inrig J; National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930. doi:10.1053/j.ajkd.2015.07.015
  • Penne EL, van der Weerd NC, Grooteman MP, et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(2):281–289. doi:10.2215/CJN.04480510
  • Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010;56(2):348–358. doi:10.1053/j.ajkd.2010.03.020
  • Casino FG, Basile C. The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant. 2017;32(1):182–190. doi:10.1093/ndt/gfw339
  • Wong J, Sridharan S, Berdeprado J, et al. Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin. Kidney Int. 2016;89(5):1090–1098. doi:10.1016/j.kint.2015.12.042
  • Chin AI, Appasamy S, Carey RJ, Madan N. Feasibility of incremental 2-times weekly hemodialysis in incident patients with residual kidney function. Kidney Int Rep. 2017;2(5):933–942. doi:10.1016/j.ekir.2017.06.005
  • Keber G, Hojs R, Dvorsak B, et al. Assessment of volume status with bioimpendance prior to hemodialysis and its importance for predicting survival in hemodialysis patients. Clin Nephrol. 2021;96(1):68–73. doi:10.5414/CNP96S12
  • Fang N, Che M, Shi L, et al. B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients. Ren Fail. 2021;43(1):1259–1265. doi:10.1080/0886022X.2021.1971091
  • Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250–257. doi:10.1038/ki.2010.383
  • Lee YJ, Okuda Y, Sy J, et al. Ultrafiltration rate, residual kidney function, and survival among patients treated with reduced-frequency hemodialysis. Am J Kidney Dis. 2020;75(3):342–350. doi:10.1053/j.ajkd.2019.08.019
  • Chaitman M, Dixit D, Bridgeman MB. Potassium-binding agents for the clinical management of hyperkalemia. Pharm Ther. 2016;41(1):43–50.
  • Bolasco P, Cupisti A, Locatelli F, Caria S, Kalantar-Zadeh K. Dietary management of incremental transition to dialysis therapy: once-weekly hemodialysis combined with low-protein diet. J Ren Nutr. 2016;26(6):352–359. doi:10.1053/j.jrn.2016.01.015
  • Bieber B, Qian J, Anand S, et al. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and quality of life in the China Dialysis Outcomes and Practice Patterns study. Nephrol Dial Transplant. 2014;29(9):1770–1777. doi:10.1093/ndt/gft472
  • Park JI, Park JT, Kim YL, et al. Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea. Nephrol Dial Transplant. 2017;32(2):355–363. doi:10.1093/ndt/gfw332
  • Suri RS, Larive B, Sherer S, et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013;24(3):498–505. doi:10.1681/ASN.2012060595
  • Hanson JA, Hulbert-Shearon TE, Ojo AO, et al. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol. 1999;19(6):625–633. doi:10.1159/000013533
  • Lin YF, Huang JW, Wu MS, et al. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology. 2009;14(1):59–64. doi:10.1111/j.1440-1797.2008.01016.x
  • Stankuvienė A, Ziginskienė E, Kuzminskis V, Bumblytė IA. Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005. Medicina. 2010;46(8):516–521. doi:10.3390/medicina46080074
  • Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia. 2012;32(6):767–776. doi:10.3265/Nefrologia.pre2012.Jul.11517
  • Elamin S, Abu-Aisha H. Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transplant. 2012;5(2):81–86.
  • Lin X, Yan Y, Ni Z, et al. Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif. 2012;33(1–3):66–72. doi:10.1159/000334634
  • Panaput T, Thinkhamrop B, Domrongkitchaiporn S, et al. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif. 2014;38(3–4):253–262. doi:10.1159/000368885
  • Zhang M, Wang M, Li H, et al. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol. 2014;40(2):140–150. doi:10.1159/000365819
  • Hwang HS, Hong YA, Yoon HE, et al. Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function. Medicine. 2016;95(7):e2767. doi:10.1097/MD.0000000000002767
  • Obi Y, Streja E, Rhee CM, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(2):256–265. doi:10.1053/j.ajkd.2016.01.008
  • Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016;90(2):262–271. doi:10.1016/j.kint.2016.02.037
  • Mukherjee T, Devi G, Geetha S, Anchan NJ, Sankarasubbaiyan S. A comparison of practice pattern and outcome of twice-weekly and thrice-weekly hemodialysis patients. Indian J Nephrol. 2017;27(3):185–189. doi:10.4103/0971-4065.202844
  • Dai L, Lu C, Liu J, et al. Impact of twice- or three-times-weekly maintenance hemodialysis on patient outcomes: a multicenter randomized trial. Medicine. 2020;99(20):e20202. doi:10.1097/MD.0000000000020202
  • Vilar E, Kaja Kamal RM, Fotheringham J, et al. A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. Kidney Int. 2021;101(3):615–625. doi:10.1016/j.kint.2021.07.025
  • Murea M, Patel A, Highland BR, et al. Twice-weekly hemodialysis with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis: a pilot study. Am J Kidney Dis. 2021. doi:10.1053/j.ajkd.2021.12.001
  • Garofalo C, Borrelli S, De Stefano T, et al. Incremental dialysis in ESRD: systematic review and meta-analysis. J Nephrol. 2019;32(5):823–836. doi:10.1007/s40620-018-00577-9
  • Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609–619. doi:10.1056/NEJMoa1000552
  • Kalantar-Zadeh K, Crowley ST, Beddhu S, et al. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017;30(3):251–261. doi:10.1111/sdi.12601